Beam Therapeutics · 1 day ago
Process Engineering Intern
Beam Therapeutics is a biotechnology company focused on precision genetic medicines. They are seeking a highly motivated Process Engineering Intern to support scale-up activities, process characterization, and data analysis for next-generation LNP formulations during the summer of 2026.
BiotechnologyGeneticsMedicalTherapeutics
Responsibilities
Formulate LNPs to determine biophysical characteristics using established assays and procedures
Participate in LNP formulation process characterization studies including mixing, filtration, and TFF (Tangential Flow Filtration) steps
Support pivotal readiness studies intended to identify key process parameters, implement in-process control strategies, and process risks
Aggregate and review GMP-related data for process development activities
Document experiment planning, execution and summarize key observations
Analyze key experimental outcomes and present them in group meetings
Adhere to all laboratory safety requirements and assist in maintaining general lab functionality
Qualification
Required
Pursuing BS or MS in Biology, Bioengineering, Biochemistry or any related field of study with 0-1 year of lab experience
Comfortable working within a highly collaborative team environment
Experience maintaining accurate laboratory notebooks and following established work instructions
Demonstrates strong analytical and critical thinking skills
Highly motivated to learn with excellent organizational and communication skills
Applicants must be currently enrolled in a degree-granting college or university program and maintain their student status throughout the duration of the internship to be eligible
Preferred
Knowledge of Excel, PowerPoint, and data analytics tools
Familiarity with process engineering concepts
Company
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Funding
Current Stage
Public CompanyTotal Funding
$1.19B2025-03-10Post Ipo Equity· $500M
2021-01-19Post Ipo Equity· $260M
2020-02-11Post Ipo Equity· $207M
Recent News
2025-12-16
2025-12-09
Company data provided by crunchbase